Madrigal Pharmaceuticals, Inc. (MDGL)

NASDAQ: MDGL · Real-Time Price · USD

Compare

579.89

+6.74 (1.18%)

At close: Dec 3, 2025, 4:00 PM EST

579.00

-0.89 (-0.15%)

After-hours: Dec 3, 2025, 7:41 PM EST

Madrigal Pharmaceuticals Market Cap

Madrigal Pharmaceuticals has a market cap or net worth of $13.17 billion as of December 3, 2025. Its market cap has increased by 99.51% in one year.

Market Cap

13.17B

Enterprise Value

12.41B

1-Year Change

99.51%

Ranking

#788

Market Cap Chart

Since March 28, 2007, Madrigal Pharmaceuticals's market cap has increased from $288.50M to $13.17B, an increase of 4,465.03%. That is a compound annual growth rate of 22.68%.

Market Cap History

Date	Market Cap	% Change
Dec 2, 2025	13.02B	93.42%
Dec 31, 2024	6.73B	47.33%
Dec 29, 2023	4.57B	-7.98%
Dec 30, 2022	4.96B	242.65%
Dec 31, 2021	1.45B	-15.74%
Dec 31, 2020	1.72B	22.31%
Dec 31, 2019	1.41B	-18.98%
Dec 31, 2018	1.74B	51.27%
Dec 29, 2017	1.15B	565.31%
Dec 30, 2016	172.40M	255.46%
Dec 31, 2015	48.50M	-83.19%
Dec 31, 2014	288.60M	-20.30%
Dec 31, 2013	362.10M	-35.14%
Dec 31, 2012	558.30M	141.48%
Dec 30, 2011	231.20M	-6.85%
Dec 31, 2010	248.20M	44.39%
Dec 31, 2009	171.90M	-17.20%
Dec 31, 2008	207.60M	-8.55%
Dec 31, 2007	227.00M	-21.32%
Mar 28, 2007	288.50M	-

View and export this data all the way back to 2007. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	936.68B
Johnson & Johnson	494.92B
AbbVie	396.55B
UnitedHealth Group	293.98B
AstraZeneca	282.37B
Novartis AG	253.36B
Merck & Co.	250.76B
Abbott Laboratories	219.65B

Market Cap Rankings